Physician profile
William G Johnson
NPI 1992791420
$2,794.39
in general payments reported to CMS, 2019-2025
20 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $257 · 2021: $188 · 2022: $768 · 2023: $570 · 2024: $254 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $502.68 | 2022-2023 | Ekosonic |
| Stryker Corporation | $486.85 | 2025 | Artix Mt, Flowtriever |
| Bayer Healthcare Pharmaceuticals INC. | $415.18 | 2022-2024 | |
| Lilly USA, LLC | $214.43 | 2020-2024 | Mounjaro, Zepbound |
| Bolton Medical INC | $150.00 | 2022 | |
| Endologix LLC | $145.18 | 2020 | |
| W. L. Gore & Associates, INC. | $133.24 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $119.23 | 2019-2024 | Farxiga, Airsupra |
| Philips North America LLC | $116.67 | 2023 | |
| Medtronic, INC. | $84.31 | 2021 | |
| Abbott Laboratories | $71.14 | 2022 | |
| Glaxosmithkline, LLC. | $60.89 | 2019 | |
| Pfizer INC. | $58.01 | 2019-2021 | |
| Baxter Healthcare | $46.83 | 2021 | |
| Novo Nordisk INC | $44.37 | 2023-2024 | Ozempic, Rybelsus |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $41.22 | 2023 | Alphavac |
| Sirtex Medical INC | $34.34 | 2022-2023 | Sir-Spheres Microspheres |
| Amgen INC. | $29.57 | 2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.14 | 2020 | |
| Lemaitre Vascular, INC. | $15.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.